Skip to main content

CC INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff Role

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Chemours (CC) To Contact Him Directly To Discuss Their Options

If you purchased or acquired Chemours securities between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Click here to participate in the action.

NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) --

What’s Happening:

  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the “Class Period”). Investors have until December 7, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Allegation Details:

  • The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (i) Defendants had materially overstated aftermarket demand for their Opteon products; (ii) demand for such products was decreasing as a result of Defendants' overselling Opteon products in the preceding fiscal year; (iii) as a result of these undisclosed issues, Defendants' financial guidance for the 2026 fiscal year was unreliable; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Next Steps:

  • If you purchased or otherwise acquired Chemours shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com.  Attorney advertising.  Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.44
+1.27 (0.48%)
AAPL  354.88
-0.75 (-0.21%)
AMD  585.30
+32.40 (5.86%)
BAC  50.51
-0.16 (-0.32%)
GOOG  295.35
+4.72 (1.62%)
META  623.61
-5.16 (-0.82%)
MSFT  523.00
+1.88 (0.36%)
NVDA  166.19
-7.54 (-4.34%)
ORCL  127.11
-1.27 (-0.99%)
TSLA  397.45
+6.61 (1.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.